OMEROMEROS CORP

Nasdaq omeros.com


$ 3.32 $ 0.15 (4.73 %)    

Thursday, 16-May-2024 10:17:04 EDT
QQQ $ 453.64 $ 0.17 (0.04 %)
DIA $ 400.33 $ 0.77 (0.19 %)
SPY $ 530.67 $ 0.74 (0.14 %)
TLT $ 92.35 $ -0.04 (-0.04 %)
GLD $ 219.57 $ -0.44 (-0.2 %)
$ 4.17
$ 3.17
$ 3.22 x 100
$ 3.31 x 100
$ 3.11 - $ 3.34
$ 0.92 - $ 7.80
453,257
na
241.63M
$ 1.44
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-13-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-02-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-01-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-01-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-08-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 03-16-2017 12-31-2016 10-K
31 11-09-2016 09-30-2016 10-Q
32 08-09-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 03-15-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 08-10-2015 06-30-2015 10-Q
37 05-11-2015 03-31-2015 10-Q
38 03-16-2015 12-31-2014 10-K
39 11-10-2014 09-30-2014 10-Q
40 08-11-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-reiterates-hold-on-omeros
Needham Reiterates Hold on Omeros
05/16/2024 10:42:27

Needham analyst Serge Belanger reiterates Omeros (NASDAQ:OMER) with a Hold.

 omeros-q1-2024-adj-eps-063-misses-058-estimate

Omeros (NASDAQ:OMER) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of $(0.58) by 8...

 correction-omeros-q4-eps-063-misses-055-estimate

Omeros (NASDAQ:OMER) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of $(0.55) by 1...

 earnings-scheduled-for-april-1-2024

Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per...

 investor-sentiment-edges-lower-us-stocks-record-gains-last-quarter

The CNN Money Fear and Greed index showed a slight decline in overall market sentiment, but it remained in the "Greed" ...

 tesla-spirit-airlines-new-york-community-bancorp-and-other-big-stocks-moving-lower-on-monday

U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.

 omeros-announces-upcoming-presentation-detailing-narsoplimab-compassionate-use-in-nine-patients-with-hematopoietic-stem-cell-transplant-associated-thrombotic-microangiopathy

Omeros Corporation (NASDAQ:OMER) today announced the upcoming presentation of a report detailing narsoplimab treatment in nine ...

 top-5-health-care-stocks-that-are-ticking-portfolio-bombs

As of Dec. 5, 2023, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a...

 insiders-buying-taysha-gene-therapies-and-3-other-stocks-under-2

The Dow Jones closed higher by over 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence ...

 cantor-fitzgerald-downgrades-omeros-to-neutral

Cantor Fitzgerald analyst Brandon Folkes downgrades Omeros (NASDAQ:OMER) from Overweight to Neutral.

 omeros-q3-eps-060-down-from-028-yoy

Omeros (NASDAQ:OMER) reported quarterly losses of $(0.60) per share. This is a 114.29 percent decrease over losses of $(0.28) p...

 recap-omeros-q3-earnings
Recap: Omeros Q3 Earnings
11/09/2023 21:35:54

 earnings-scheduled-for-november-9-2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on re...

 earnings-preview-omeros
Earnings Preview: Omeros
11/08/2023 16:01:03

 omeros-announces-online-publication-in-advance-of-ash-annual-meeting-detailing-narsoplimab-treatment-under-compassionate-use-of-15-patients-with-hematopoietic-stem-cell-transplant-associated-thrombotic-microangiopathy

-- Poster Presentation Slated for Upcoming Annual Meeting of the American Society of Hematology --

 crude-oil-moves-lower-consolidated-communications-shares-jump

U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining over 1% on Monday. The Dow traded up 0.93% t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION